SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016945
Filing Date
2017-08-09
Accepted
2017-08-09 16:07:20
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 Q3 2017 10-Q enta-10q_20170630.htm 10-Q 2078672
2 EX-31.1 enta-ex311_7.htm EX-31.1 16198
3 EX-31.2 enta-ex312_6.htm EX-31.2 16184
4 EX-32.1 enta-ex321_8.htm EX-32.1 8923
5 GRAPHIC g201708091436411914435.jpg GRAPHIC 49114
  Complete submission text file 0001564590-17-016945.txt   6914892

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20170630.xml EX-101.INS 1631739
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20170630.xsd EX-101.SCH 35289
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20170630_cal.xml EX-101.CAL 44348
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20170630_def.xml EX-101.DEF 113015
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20170630_lab.xml EX-101.LAB 296484
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20170630_pre.xml EX-101.PRE 251015
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 171017911
SIC: 2834 Pharmaceutical Preparations